Oct 232017
 

By Talent4Boards Team

Talent4Boards – Great Talent builds Great Boards

– USA, CA – Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics, today announced that its Board of Directors has selected Aron Knickerbocker to succeed Lewis T.… => Read more

Five Prime Therapeutics announces COO Aron Knickerbocker as CEO designate

From:: Five Prime Therapeutics announces COO Aron Knickerbocker as CEO designate

Sorry, the comment form is closed at this time.

%d bloggers like this: